ElMindA to Present at the Eleventh World Congress on Brain Injury: BNA™ As a Physiological Marker for Sports-Related Concussion

CHICAGO, March 2, 2016 /PRNewswire/ -- ElMindA Ltd. will present on the ongoing clinical evaluation of utilizing BNA™ (Brain Network Activation) in sports-related concussion at the Eleventh World Congress on Brain Injury on March 3, 2016 in Hague, Netherlands. The research presented will examine a novel approach utilizing BNA to assess sports concussion through electrophysiological network activity which underlies brain function and dysfunction. BNA is a non-invasive test that uses advanced signal processing and machine-learning algorithms of populations' data in order to identify patterns of neuronal networks activated during a specific brain function, such as memory or attention.

Nearly 21 percent of all traumatic brain injuries among American children and adolescents are related to sports and recreational activities. BNA has been used as a clinical management tool for medical professionals to provide an objective measure of brain function in a healthy state and after sustaining a brain injury. BNA was cleared by the FDA in 2014 for the post-hoc statistical analysis of EEG/ERP, for use in 14 to 24 year-olds. ElMindA is expecting to expand the indicated age group with the FDA this year. BNA also received CE mark in the EU for analysis of EEG to aid in clinical diagnosis and treatment management.

"BNA is a valuable resource for clinical professionals who work closely with brain injuries and disorders. Through BNA's objective measurement of network activity, clinicians are able to generate more informed patient treatment decisions when dealing with complex brain injuries like concussion. Our abstract presentation will allow the scientific community to better understand the role BNA can play in sports-related head injuries—a troubling and constant concern for athletes of all ages," said Amit Reches, PhD, Executive Vice President of Research and Development at ElMindA.

ElMindA is scheduled to present the following:
Preliminary Investigation of Brain Network Activation (BNA) Following Sport-Related Concussion
[Abstract #0839]
Session ID: AP4C - Accepted Papers 4C Neuroimaging of Sports Concussion
Thursday, March 3, 2016
4:00pm - 5:30pm

The Eleventh World Congress on Brain Injury is held biennially by the International Brain Injury Association, and is the largest gathering of international professionals working in the field of brain injury.

About BNA™

BNA™ is a breakthrough technology to monitor and manage the health of your brain. It combines non-invasive, multi-channel EEG technology with sophisticated signal processing and analysis algorithms to measure patterns of brain networks activated during specific brain processes to deliver meaningful insights into brain functionality. In addition to concussion, use of BNA is being explored as a tool for physicians to monitor change in brain networks to help identify disease onset and assess treatment efficacy for a broad range of previously elusive conditions such as depression, pain, or memory loss. The BNA Analysis System is to be used by qualified medical professionals for the post-hoc analysis of the human Electroencephalogram (EEG), utilizing evoked response potentials (ERP). The device is indicated in the U.S. for use in individuals 14 to 24 years of age with the Auditory Oddball task only. BNA is currently available to healthcare providers at 15 locations in eight U.S. cities, including Chicago, Los Angeles, Philadelphia, Minneapolis, Phoenix, Ann Arbor, Hartford, and Palm Beach. For more information about BNA visit, www.MyBNA.com.

About ElMindA Ltd.

ElMindA was founded in 2006 by Professor Amir Geva to address an unmet need to objectively assess brain health and brain-related disorders in order to enhance diagnosis and treatment across a full spectrum of neurological and psychological disorders. ElMindA translates state-of-the-art neuroscience via advanced algorithmic science into clinically meaningful Brain Network Activation (BNA™) maps. ElMindA is a preferred partner of industry-leading organizations based on the rigor of its science and technology development. ElMindA was named a Technology Pioneer by the World Economic Forum in 2015.